

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.54857487 |
| 2 | regulation of vitamin metabolic process (GO:0030656) | 5.11703896 |
| 3 | regulation of mononuclear cell migration (GO:0071675) | 4.75602175 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 4.45557446 |
| 5 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.43781800 |
| 6 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.35617692 |
| 7 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.22511435 |
| 8 | positive regulation of heat generation (GO:0031652) | 4.20032427 |
| 9 | regulation of podosome assembly (GO:0071801) | 4.19888889 |
| 10 | response to peptidoglycan (GO:0032494) | 4.18566482 |
| 11 | regulation of fever generation (GO:0031620) | 4.17776768 |
| 12 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.15238029 |
| 13 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.10707358 |
| 14 | regulation of chronic inflammatory response (GO:0002676) | 4.10525351 |
| 15 | T-helper 1 type immune response (GO:0042088) | 4.07539053 |
| 16 | eosinophil chemotaxis (GO:0048245) | 3.91459387 |
| 17 | glycosphingolipid catabolic process (GO:0046479) | 3.83413449 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 3.81220434 |
| 19 | monocyte chemotaxis (GO:0002548) | 3.74420498 |
| 20 | NIK/NF-kappaB signaling (GO:0038061) | 3.73854676 |
| 21 | regulation of chemokine biosynthetic process (GO:0045073) | 3.73294986 |
| 22 | positive regulation of type 2 immune response (GO:0002830) | 3.69461867 |
| 23 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.67788896 |
| 24 | glycolipid catabolic process (GO:0019377) | 3.54542473 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.51073214 |
| 26 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.51030770 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 3.50080867 |
| 28 | eosinophil migration (GO:0072677) | 3.45865044 |
| 29 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.44172905 |
| 30 | myeloid dendritic cell differentiation (GO:0043011) | 3.43047143 |
| 31 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.42995004 |
| 32 | oligosaccharide catabolic process (GO:0009313) | 3.41532925 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.40462741 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.40462741 |
| 35 | regulation of interferon-alpha production (GO:0032647) | 3.36891658 |
| 36 | response to type I interferon (GO:0034340) | 3.35215500 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30349245 |
| 38 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.28925699 |
| 39 | response to protozoan (GO:0001562) | 3.22415746 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.21141987 |
| 41 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.19170466 |
| 42 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.18880922 |
| 43 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.18685791 |
| 44 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.17933990 |
| 45 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.17817675 |
| 46 | defense response to protozoan (GO:0042832) | 3.17192936 |
| 47 | regulation of heat generation (GO:0031650) | 3.15774944 |
| 48 | cellular response to lipopolysaccharide (GO:0071222) | 3.15586337 |
| 49 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.11100176 |
| 50 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.09821458 |
| 51 | regulation of interleukin-12 production (GO:0032655) | 3.09057334 |
| 52 | indolalkylamine catabolic process (GO:0046218) | 3.08323343 |
| 53 | tryptophan catabolic process (GO:0006569) | 3.08323343 |
| 54 | indole-containing compound catabolic process (GO:0042436) | 3.08323343 |
| 55 | adhesion of symbiont to host cell (GO:0044650) | 3.07409447 |
| 56 | virion attachment to host cell (GO:0019062) | 3.07409447 |
| 57 | ceramide catabolic process (GO:0046514) | 3.05606863 |
| 58 | cellular response to molecule of bacterial origin (GO:0071219) | 3.04730615 |
| 59 | kynurenine metabolic process (GO:0070189) | 3.03002620 |
| 60 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.02710597 |
| 61 | lymphocyte chemotaxis (GO:0048247) | 3.00853683 |
| 62 | membrane lipid catabolic process (GO:0046466) | 3.00330538 |
| 63 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.99026822 |
| 64 | cellular response to interferon-gamma (GO:0071346) | 2.98501515 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 2.97389284 |
| 66 | regulation of T-helper cell differentiation (GO:0045622) | 2.95998492 |
| 67 | response to interferon-gamma (GO:0034341) | 2.95762530 |
| 68 | regulation of type 2 immune response (GO:0002828) | 2.92810209 |
| 69 | detection of molecule of bacterial origin (GO:0032490) | 2.92804292 |
| 70 | regulation of macrophage chemotaxis (GO:0010758) | 2.92456458 |
| 71 | dendritic cell differentiation (GO:0097028) | 2.91440812 |
| 72 | sphingolipid catabolic process (GO:0030149) | 2.91414237 |
| 73 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90598603 |
| 74 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.90394054 |
| 75 | positive regulation of acute inflammatory response (GO:0002675) | 2.89545931 |
| 76 | granulocyte activation (GO:0036230) | 2.88585654 |
| 77 | regulation of antigen processing and presentation (GO:0002577) | 2.87500312 |
| 78 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.86525260 |
| 79 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.85768006 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 2.85694204 |
| 81 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.85137884 |
| 82 | germinal center formation (GO:0002467) | 2.83704473 |
| 83 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.83535985 |
| 84 | positive regulation of interferon-alpha production (GO:0032727) | 2.82656561 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82322749 |
| 86 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81889876 |
| 87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.81301093 |
| 88 | positive regulation of interleukin-12 production (GO:0032735) | 2.81050953 |
| 89 | angiotensin maturation (GO:0002003) | 2.80876885 |
| 90 | regulation of immunoglobulin secretion (GO:0051023) | 2.79651918 |
| 91 | negative regulation of lipid storage (GO:0010888) | 2.79540094 |
| 92 | B cell mediated immunity (GO:0019724) | 2.78916623 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.77247855 |
| 94 | positive regulation of interleukin-6 production (GO:0032755) | 2.72504217 |
| 95 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.71429003 |
| 96 | positive regulation of interleukin-10 production (GO:0032733) | 2.70737125 |
| 97 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.70460762 |
| 98 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.70320041 |
| 99 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.68893611 |
| 100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.68879969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.84645657 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.15144682 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.65387873 |
| 4 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 4.48688434 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.32388767 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.60544722 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.34626163 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.30066482 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10388091 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.99268365 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.88357080 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.52751733 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44320772 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43040951 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.32958635 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.15768675 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.11264165 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10950547 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08963234 |
| 20 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96915007 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.91595610 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73799058 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68980701 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68142080 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66199381 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65308784 |
| 27 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65009429 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64969840 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62462647 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58793737 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58668502 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56491005 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54480372 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54362090 |
| 35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.49699120 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48451055 |
| 37 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46190475 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.43080863 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42907409 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36462033 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36357577 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36172454 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36093194 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.34075344 |
| 45 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32623785 |
| 46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32332404 |
| 47 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.31972503 |
| 48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30184239 |
| 49 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27082235 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23564281 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22537687 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21183582 |
| 53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19125114 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19106984 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18919601 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17165969 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16931144 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15029807 |
| 59 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14280816 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12390220 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11355389 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10675204 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09788249 |
| 64 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09167694 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08653192 |
| 66 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07615091 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06969429 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06699868 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.02191548 |
| 70 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99582811 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99459640 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97284775 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96988684 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96640192 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96571221 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96516762 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96351357 |
| 78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96044229 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94803908 |
| 80 | MAF_26560356_Chip-Seq_TH1_Human | 0.92420975 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92106498 |
| 82 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90566799 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88379022 |
| 84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87814959 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86063896 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84584221 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84054385 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.83878319 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83560667 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82008532 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81924133 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80486359 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80485612 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79200968 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79062356 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78450922 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78051393 |
| 98 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77703860 |
| 99 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.77585832 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.77585832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.93090157 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.78420618 |
| 3 | MP0006082_CNS_inflammation | 3.68609940 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.59079604 |
| 5 | MP0009785_altered_susceptibility_to | 3.50134100 |
| 6 | MP0003724_increased_susceptibility_to | 3.26532262 |
| 7 | MP0009840_abnormal_foam_cell | 3.19215605 |
| 8 | MP0003436_decreased_susceptibility_to | 3.05090943 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.99747171 |
| 10 | MP0004510_myositis | 2.89926005 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.71740269 |
| 12 | MP0009764_decreased_sensitivity_to | 2.52887411 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.50686170 |
| 14 | MP0001790_abnormal_immune_system | 2.42031351 |
| 15 | MP0005387_immune_system_phenotype | 2.42031351 |
| 16 | MP0005025_abnormal_response_to | 2.40598007 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.37154682 |
| 18 | MP0002419_abnormal_innate_immunity | 2.34844642 |
| 19 | MP0005671_abnormal_response_to | 2.33550054 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.23277898 |
| 21 | MP0003075_altered_response_to | 2.23275511 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.19423655 |
| 23 | MP0000343_altered_response_to | 2.18297174 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.00078875 |
| 25 | MP0002723_abnormal_immune_serum | 1.93127508 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.91422928 |
| 27 | MP0001800_abnormal_humoral_immune | 1.90409164 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.88307059 |
| 29 | MP0004947_skin_inflammation | 1.87888286 |
| 30 | MP0008004_abnormal_stomach_pH | 1.81148018 |
| 31 | MP0002254_reproductive_system_inflammat | 1.80051601 |
| 32 | MP0005166_decreased_susceptibility_to | 1.76125896 |
| 33 | MP0008469_abnormal_protein_level | 1.70108146 |
| 34 | MP0000685_abnormal_immune_system | 1.69692948 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.67297876 |
| 36 | MP0005451_abnormal_body_composition | 1.66985733 |
| 37 | MP0000604_amyloidosis | 1.63493817 |
| 38 | MP0009278_abnormal_bone_marrow | 1.61839016 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.59339747 |
| 40 | MP0003195_calcinosis | 1.58337577 |
| 41 | MP0001853_heart_inflammation | 1.55198244 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.54531823 |
| 43 | MP0006054_spinal_hemorrhage | 1.53582212 |
| 44 | MP0001819_abnormal_immune_cell | 1.52644576 |
| 45 | MP0003448_altered_tumor_morphology | 1.51606524 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.50192050 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.48967606 |
| 48 | MP0005310_abnormal_salivary_gland | 1.48810976 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.46196592 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.42619577 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.33983106 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.33983106 |
| 53 | MP0003690_abnormal_glial_cell | 1.33781556 |
| 54 | MP0002405_respiratory_system_inflammati | 1.33649506 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.32607656 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.21434660 |
| 57 | MP0001663_abnormal_digestive_system | 1.20473885 |
| 58 | MP0000858_altered_metastatic_potential | 1.18902544 |
| 59 | MP0001873_stomach_inflammation | 1.18862602 |
| 60 | MP0005365_abnormal_bile_salt | 1.17596354 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.13985022 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.11725202 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.10544731 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.01875989 |
| 65 | MP0000716_abnormal_immune_system | 1.01744038 |
| 66 | MP0005164_abnormal_response_to | 1.01248504 |
| 67 | MP0005165_increased_susceptibility_to | 0.97123858 |
| 68 | MP0009763_increased_sensitivity_to | 0.92736707 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 0.92309849 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.92070937 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.89786225 |
| 72 | MP0000920_abnormal_myelination | 0.87808342 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 0.86945388 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.85771590 |
| 75 | MP0005360_urolithiasis | 0.83383969 |
| 76 | MP0005381_digestive/alimentary_phenotyp | 0.82932907 |
| 77 | MP0003329_amyloid_beta_deposits | 0.78549104 |
| 78 | MP0001542_abnormal_bone_strength | 0.74793959 |
| 79 | MP0005390_skeleton_phenotype | 0.74101521 |
| 80 | MP0003866_abnormal_defecation | 0.73330352 |
| 81 | MP0002429_abnormal_blood_cell | 0.73199625 |
| 82 | MP0000609_abnormal_liver_physiology | 0.71846027 |
| 83 | MP0008874_decreased_physiological_sensi | 0.71408819 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.71046759 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.70361679 |
| 86 | MP0005023_abnormal_wound_healing | 0.70116659 |
| 87 | MP0003091_abnormal_cell_migration | 0.69158233 |
| 88 | MP0002398_abnormal_bone_marrow | 0.68693725 |
| 89 | MP0000249_abnormal_blood_vessel | 0.68348436 |
| 90 | MP0005535_abnormal_body_temperature | 0.66992833 |
| 91 | MP0000490_abnormal_crypts_of | 0.66747904 |
| 92 | MP0003795_abnormal_bone_structure | 0.65951380 |
| 93 | MP0004043_abnormal_pH_regulation | 0.64128930 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.63024915 |
| 95 | MP0001666_abnormal_nutrient_absorption | 0.61830200 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.61532529 |
| 97 | MP0001764_abnormal_homeostasis | 0.61259442 |
| 98 | MP0005647_abnormal_sex_gland | 0.60253085 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.58346846 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.57839645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.71182713 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.71182713 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.71182713 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.05921314 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.03112363 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.74646199 |
| 7 | Loss of speech (HP:0002371) | 4.47233791 |
| 8 | Disinhibition (HP:0000734) | 4.33436331 |
| 9 | Dysostosis multiplex (HP:0000943) | 4.09162401 |
| 10 | Orchitis (HP:0100796) | 4.06061991 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.97139910 |
| 12 | Optic neuritis (HP:0100653) | 3.97139910 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 3.95678314 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.92536311 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.87269637 |
| 16 | Stomatitis (HP:0010280) | 3.61323466 |
| 17 | Mutism (HP:0002300) | 3.58672576 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.57385819 |
| 19 | Malnutrition (HP:0004395) | 3.53608477 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.51855107 |
| 21 | Myositis (HP:0100614) | 3.50197995 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.47391002 |
| 23 | Glomerulonephritis (HP:0000099) | 3.30251823 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.20399891 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.19543287 |
| 26 | Nuclear cataract (HP:0100018) | 3.18964498 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.17920224 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.17920224 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.17920224 |
| 30 | Axonal loss (HP:0003447) | 3.14410608 |
| 31 | Nausea (HP:0002018) | 3.03689429 |
| 32 | Mucopolysacchariduria (HP:0008155) | 3.03405919 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03405919 |
| 34 | Amyloidosis (HP:0011034) | 2.97939588 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 2.73292280 |
| 36 | Metaphyseal irregularity (HP:0003025) | 2.72969109 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72141252 |
| 38 | Hematochezia (HP:0002573) | 2.71922309 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.66762565 |
| 40 | Increased serum ferritin (HP:0003281) | 2.64322704 |
| 41 | Vasculitis (HP:0002633) | 2.61149465 |
| 42 | Apathy (HP:0000741) | 2.59655729 |
| 43 | Gangrene (HP:0100758) | 2.56436191 |
| 44 | Hemoptysis (HP:0002105) | 2.54517830 |
| 45 | Diminished motivation (HP:0000745) | 2.53795628 |
| 46 | Progressive neurologic deterioration (HP:0002344) | 2.52187506 |
| 47 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.50603009 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.49947125 |
| 49 | Myocardial infarction (HP:0001658) | 2.49902425 |
| 50 | Increased IgM level (HP:0003496) | 2.49891625 |
| 51 | Complement deficiency (HP:0004431) | 2.49026720 |
| 52 | Petechiae (HP:0000967) | 2.41427677 |
| 53 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.35053220 |
| 54 | Prolonged neonatal jaundice (HP:0006579) | 2.31112949 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.30762966 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30234409 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29303060 |
| 58 | Obstructive lung disease (HP:0006536) | 2.29303060 |
| 59 | Inappropriate behavior (HP:0000719) | 2.28806218 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.28647335 |
| 61 | Polyneuropathy (HP:0001271) | 2.17679014 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.17433081 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 2.17259310 |
| 64 | Thin bony cortex (HP:0002753) | 2.15522995 |
| 65 | Neuronal loss in central nervous system (HP:0002529) | 2.11358747 |
| 66 | Abnormality of complement system (HP:0005339) | 2.10491358 |
| 67 | Bone pain (HP:0002653) | 2.09310425 |
| 68 | Purpura (HP:0000979) | 2.08719190 |
| 69 | Basal ganglia calcification (HP:0002135) | 2.06046187 |
| 70 | Hyperparathyroidism (HP:0000843) | 2.05990180 |
| 71 | Anorexia (HP:0002039) | 2.04889047 |
| 72 | Recurrent skin infections (HP:0001581) | 2.04735501 |
| 73 | Parakeratosis (HP:0001036) | 2.04448528 |
| 74 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.03931047 |
| 75 | Gingivitis (HP:0000230) | 2.01479383 |
| 76 | Dementia (HP:0000726) | 2.01215608 |
| 77 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.99672449 |
| 78 | Agnosia (HP:0010524) | 1.99301042 |
| 79 | Chronic diarrhea (HP:0002028) | 1.98921044 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 1.98219234 |
| 81 | Hypophosphatemia (HP:0002148) | 1.98180074 |
| 82 | Premature loss of primary teeth (HP:0006323) | 1.96572446 |
| 83 | Hepatosplenomegaly (HP:0001433) | 1.94686308 |
| 84 | Joint swelling (HP:0001386) | 1.94651787 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92701327 |
| 86 | Abnormality of the pleura (HP:0002103) | 1.89934754 |
| 87 | Steatorrhea (HP:0002570) | 1.89463808 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 1.87581670 |
| 89 | Recurrent viral infections (HP:0004429) | 1.86734994 |
| 90 | Protuberant abdomen (HP:0001538) | 1.86427566 |
| 91 | Nephritis (HP:0000123) | 1.84615143 |
| 92 | Fat malabsorption (HP:0002630) | 1.82178695 |
| 93 | T lymphocytopenia (HP:0005403) | 1.82013314 |
| 94 | Pancreatitis (HP:0001733) | 1.81752771 |
| 95 | Urticaria (HP:0001025) | 1.80867037 |
| 96 | Acne (HP:0001061) | 1.80197067 |
| 97 | Recurrent fungal infections (HP:0002841) | 1.80004665 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 1.79955461 |
| 99 | Peripheral demyelination (HP:0011096) | 1.79518073 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 1.78558333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.98450834 |
| 2 | NME2 | 4.07866026 |
| 3 | GRK7 | 3.48998627 |
| 4 | MAP3K14 | 3.39306795 |
| 5 | ACVR1B | 3.06965188 |
| 6 | DDR2 | 2.98292245 |
| 7 | MATK | 2.84665985 |
| 8 | TAOK2 | 2.74201581 |
| 9 | TBK1 | 2.68891618 |
| 10 | RIPK1 | 2.52710812 |
| 11 | BLK | 2.48878049 |
| 12 | TYK2 | 2.21936732 |
| 13 | IKBKB | 2.20298155 |
| 14 | TAOK1 | 2.15761190 |
| 15 | IKBKE | 1.98015803 |
| 16 | RIPK4 | 1.96895957 |
| 17 | PIM2 | 1.92790547 |
| 18 | IRAK4 | 1.92170457 |
| 19 | MAP3K11 | 1.90047789 |
| 20 | ERN1 | 1.87428897 |
| 21 | ADRBK2 | 1.83764368 |
| 22 | FGR | 1.82981916 |
| 23 | MAP3K3 | 1.80108620 |
| 24 | BMPR2 | 1.73270869 |
| 25 | CSK | 1.72381241 |
| 26 | TGFBR2 | 1.58650635 |
| 27 | MOS | 1.53763813 |
| 28 | TXK | 1.46745480 |
| 29 | CDC42BPA | 1.42695078 |
| 30 | PRPF4B | 1.41466854 |
| 31 | ABL2 | 1.41328499 |
| 32 | MAP4K1 | 1.40255591 |
| 33 | JAK3 | 1.36644632 |
| 34 | CHUK | 1.36554116 |
| 35 | MAP3K13 | 1.19295812 |
| 36 | MAP3K1 | 1.16578555 |
| 37 | JAK1 | 1.04416078 |
| 38 | LYN | 1.02580510 |
| 39 | MST1R | 1.00349841 |
| 40 | IRAK1 | 1.00258276 |
| 41 | STK24 | 0.96217096 |
| 42 | ZAP70 | 0.93158681 |
| 43 | MAP2K3 | 0.91678418 |
| 44 | MAP2K6 | 0.91488061 |
| 45 | MAP3K5 | 0.89374559 |
| 46 | IRAK2 | 0.88933287 |
| 47 | PRKG2 | 0.85785253 |
| 48 | LMTK2 | 0.83802993 |
| 49 | TESK1 | 0.79574892 |
| 50 | JAK2 | 0.78377384 |
| 51 | MAP3K12 | 0.76873521 |
| 52 | DAPK2 | 0.68539300 |
| 53 | LATS2 | 0.65635850 |
| 54 | SYK | 0.65516924 |
| 55 | EPHA3 | 0.65251779 |
| 56 | ARAF | 0.63760403 |
| 57 | TESK2 | 0.61835208 |
| 58 | SIK3 | 0.61698010 |
| 59 | CSF1R | 0.61068395 |
| 60 | PDK2 | 0.59477992 |
| 61 | MST4 | 0.57563958 |
| 62 | TAOK3 | 0.53689235 |
| 63 | PIM1 | 0.52942050 |
| 64 | TYRO3 | 0.52849236 |
| 65 | LCK | 0.50559148 |
| 66 | MARK3 | 0.49078096 |
| 67 | STK10 | 0.45972976 |
| 68 | KIT | 0.45473041 |
| 69 | PAK4 | 0.45452021 |
| 70 | CAMKK2 | 0.41485323 |
| 71 | BMX | 0.39807381 |
| 72 | PDPK1 | 0.37316575 |
| 73 | DAPK3 | 0.36809823 |
| 74 | CLK1 | 0.36768308 |
| 75 | HCK | 0.35919250 |
| 76 | EPHA2 | 0.33957409 |
| 77 | PDGFRA | 0.33701225 |
| 78 | EPHB2 | 0.31980003 |
| 79 | ABL1 | 0.31600751 |
| 80 | EPHB1 | 0.31506681 |
| 81 | DYRK3 | 0.31307177 |
| 82 | CDK6 | 0.31165275 |
| 83 | MAPK4 | 0.31029315 |
| 84 | PDK1 | 0.30498117 |
| 85 | HIPK2 | 0.28416711 |
| 86 | BTK | 0.25089068 |
| 87 | FGFR4 | 0.24278359 |
| 88 | RPS6KC1 | 0.23847413 |
| 89 | RPS6KL1 | 0.23847413 |
| 90 | PRKAA2 | 0.23321784 |
| 91 | EGFR | 0.22875350 |
| 92 | PRKCD | 0.22578631 |
| 93 | CAMK2D | 0.20793190 |
| 94 | GSK3A | 0.20565849 |
| 95 | INSR | 0.19897627 |
| 96 | PRKACG | 0.18738625 |
| 97 | CAMK2G | 0.16999338 |
| 98 | RPS6KA6 | 0.16776567 |
| 99 | MAPKAPK2 | 0.16696074 |
| 100 | FYN | 0.16580209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.08889616 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.93818353 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.93127135 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.88133644 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.61832168 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.56394517 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.55696525 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.50961537 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.46361043 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.37363500 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.35415487 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.28023543 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.27750026 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25727509 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22910058 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.17068366 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.16903158 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 2.16873535 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 2.12557722 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05031825 |
| 21 | Malaria_Homo sapiens_hsa05144 | 2.03115993 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.96059275 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.94618311 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.86995313 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.77435523 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.73983868 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.72185687 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69088334 |
| 29 | Mineral absorption_Homo sapiens_hsa04978 | 1.68081993 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.66393829 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.64707451 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.52743961 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49828120 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38074699 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.32888916 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20802431 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.19653222 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 1.16848391 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15820295 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14307130 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10546077 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09972659 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99605550 |
| 44 | Measles_Homo sapiens_hsa05162 | 0.98948664 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 0.96282115 |
| 46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93587293 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91524328 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85646606 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.82153778 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.81458037 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.77073761 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75233552 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74931038 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.74909086 |
| 55 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73440334 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.70932170 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70868457 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.69306515 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67051554 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66579954 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63618454 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59966705 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58229313 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56060563 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53703939 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53344754 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51458270 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51346868 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49934238 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44578775 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43219924 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42332912 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42052664 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41327983 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39513052 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39246110 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38878197 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37873675 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35214326 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34845926 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.32943037 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.31931443 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30831183 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27062860 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24498090 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23199898 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.22951925 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22521722 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21405035 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21224816 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.20842584 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20136358 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18962896 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.18222532 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17804641 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16109033 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16098074 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15740161 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.15647008 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14418284 |

